A constitutive activation of PI3K/AKT signaling is also frequently seen in cancer, where SOX2 expression functionally coincides with the CSC compartment and its implication in treatment resistance, tumor dissemination, and relapse. This evidence concerns the gene SOX2 and neoplasm.